EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 178 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -33.3% | 70 | +9.4% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 64 | -16.9% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 77 | +126.5% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 34 | +100.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 17 | -45.2% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 31 | -40.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 52 | +23.8% | 0.00% | – |
| Q3 2020 | $2,000 | – | 42 | +425.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 8 | -98.9% | 0.00% | -100.0% |
| Q4 2019 | $44,000 | +266.7% | 741 | +233.8% | 0.00% | +200.0% |
| Q3 2019 | $12,000 | +500.0% | 222 | +441.5% | 0.00% | – |
| Q2 2019 | $2,000 | -98.6% | 41 | -98.0% | 0.00% | -100.0% |
| Q3 2018 | $146,000 | -99.9% | 2,097 | +12.4% | 0.01% | -8.3% |
| Q2 2018 | $141,183,000 | +470510.0% | 1,866 | +232.6% | 0.01% | +300.0% |
| Q1 2018 | $30,000 | +233.3% | 561 | +208.2% | 0.00% | +200.0% |
| Q4 2017 | $9,000 | -82.0% | 182 | -78.4% | 0.00% | -80.0% |
| Q3 2017 | $50,000 | -12.3% | 842 | +16.6% | 0.01% | 0.0% |
| Q2 2017 | $57,000 | +1325.0% | 722 | +1237.0% | 0.01% | – |
| Q1 2017 | $4,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -91.3% | 54 | -95.5% | 0.00% | -100.0% |
| Q2 2016 | $46,000 | -82.6% | 1,197 | -81.7% | 0.00% | -84.0% |
| Q1 2016 | $264,000 | -86.7% | 6,524 | -70.8% | 0.02% | -86.0% |
| Q4 2015 | $1,980,000 | – | 22,334 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |